HUNTINGTON NATIONAL BANK - THERAVANCE INC ownership

THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 30 filers reported holding THERAVANCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of THERAVANCE INC
ValueSharesWeighting
Q3 2023$10.0%10.0%0.00%
Q2 2023$10.0%10.0%0.00%
Q1 2023$10.0%10.0%0.00%
Q4 2022$110.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$010.00%
Other shareholders
THERAVANCE INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wellesley Asset Management 41,771$44,921,0002.37%
LINDEN ADVISORS LP 45,495,000$48,853,0001.16%
BASSO CAPITAL MANAGEMENT, L.P. 4,759,000$5,092,0000.94%
SSI INVESTMENT MANAGEMENT LLC 6,850,000$7,332,0000.60%
TEALWOOD ASSET MANAGEMENT INC 1,390,000$1,492,0000.59%
Castle Creek Arbitrage, LLC 6,070,000$6,516,0000.48%
OAKTREE CAPITAL MANAGEMENT LP 21,717,000$23,355,0000.37%
AQR Arbitrage LLC 27,018,000$29,055,0000.34%
CSS LLC/IL 5,000,000$5,360,0000.27%
CQS Cayman LP 4,150,000$4,469,0000.21%
View complete list of THERAVANCE INC shareholders